Insights · Cataract

Anisometropia after cataract surgery: predictable risk or avoidable harm?

Refractive imbalance between the eyes is a recognised consequence of staged cataract surgery. Litigation often arises when patients feel unprepared for its functional impact.

Commentary by Professor Irfan Jeeva, Consultant Ophthalmologist and Expert Witness

This article examines how anisometropia is analysed retrospectively by the court, and how experts distinguish between an accepted, temporary consequence of treatment and avoidable harm.

Understanding anisometropia in cataract pathways

Anisometropia occurs when there is a significant refractive difference between the operated and unoperated eye, most commonly after first-eye surgery when the fellow eye remains cataractous or highly ametropic. Clinically it is expected in many staged pathways. Medico-legally, the issue is not its occurrence, but whether it was anticipated, discussed, and appropriately managed.

Functional impact matters more than dioptres

From a patient's perspective, anisometropia is rarely experienced as a numerical difference; it is experienced functionally: loss of binocular vision, diplopia or visual discomfort, imbalance when walking or on stairs, difficulty driving or reading, and intolerance of spectacle correction. Experts are often asked whether these consequences were foreseeable and whether patients were adequately prepared for them.

Consent and expectation management

A central question is whether the patient understood that first-eye surgery might temporarily worsen their overall visual function. Consent discussions should explore the likelihood of refractive imbalance, the impact on daily activities, the duration of symptoms, interim management options, and the plan and timing for second-eye surgery. Where these discussions are absent or poorly documented, courts may conclude anisometropia was not meaningfully explained.

Timing of second-eye surgery

The interval between first and second-eye surgery is a frequent focus. While delays may be driven by service pressures or medical factors, experts assess whether the interval was reasonable, considering severity of anisometropia, patient symptoms and functional impairment, availability of interim solutions, and whether delay exacerbated harm. Prolonged delay without reassessment or mitigation may be difficult to defend.

Interim management options

Anisometropia can often be managed temporarily through non-surgical means, and failure to discuss or offer these may contribute to claims: contact lens use in the unoperated eye, refractive adjustment of spectacles, patching in selected cases, and prioritisation of second-eye surgery. Experts may be asked whether reasonable steps were taken to minimise functional impact during the interim period.

First-eye outcomes and planning

An unexpected refractive result in the first eye can exacerbate anisometropia. Courts examine whether the outcome prompted reconsideration of the second-eye plan: whether prediction error was recognised, whether the second-eye target was adjusted, and whether further discussion occurred. Proceeding without reassessment may suggest a failure to adapt to evolving circumstances.

Causation and avoidability

Anisometropia itself is not negligence. The analysis focuses on whether harm arose from how it was handled: whether the patient would have proceeded had they been properly informed, whether earlier second-eye surgery would have reduced harm, and whether interim management would have mitigated symptoms. This requires careful separation of unavoidable consequences from avoidable functional loss.

Conclusion

Anisometropia sits in a grey zone between expected consequence and potential harm. Courts focus not on its existence, but on whether it was anticipated, explained, and managed reasonably. Approached transparently and responsively, it is usually defensible; overlooked or underestimated, it can become the focal point of litigation.

Frequently asked questions

What is anisometropia after cataract surgery?

Anisometropia occurs when there is a significant refractive difference between the operated and unoperated eye, most commonly after first-eye surgery when the fellow eye remains cataractous or highly ametropic. Clinically it is expected in many staged pathways. Medico-legally, the issue is not its occurrence, but whether it was anticipated, discussed, and appropriately managed.

How should consent address the risk of anisometropia?

A central question is whether the patient understood that first-eye surgery might temporarily worsen their overall visual function. Consent discussions should explore the likelihood of refractive imbalance, the impact on daily activities, the duration of symptoms, interim management options, and the plan and timing for second-eye surgery. Where these discussions are absent or poorly documented, courts may conclude anisometropia was not meaningfully explained.

When does anisometropia become avoidable harm rather than an expected consequence?

Anisometropia itself is not negligence. The analysis focuses on whether harm arose from how it was handled: whether the patient would have proceeded had they been properly informed, whether earlier second-eye surgery would have reduced harm, and whether interim management would have mitigated symptoms. This requires careful separation of unavoidable consequences from avoidable functional loss.